{"product_id":"gmp-microbiology-laboratory-sterility-testing-guide","title":"Operational Guide to the GMP Microbiology Laboratory and Sterility Testing (First Edition + Toolkit)","description":"\u003cdiv style=\"font-family:-apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Helvetica,Arial,sans-serif;color:#33241F;line-height:1.65\"\u003e\u003cdiv style=\"background:#2B1E1A;border-radius:14px;padding:34px 30px 30px 30px;color:#ffffff;margin-bottom:26px;border-bottom:4px solid #EC6FA9\"\u003e\u003cdiv style=\"display:inline-block;background:#EC6FA9;color:#2B1E1A;font-size:12px;font-weight:700;letter-spacing:1.6px;text-transform:uppercase;padding:6px 12px;border-radius:4px;margin-bottom:16px\"\u003eFirst edition · v1.0 · regulatory verification 04\/10\/2026\u003c\/div\u003e\u003ch3 style=\"margin:0 0 12px 0;font-size:28px;line-height:1.25;color:#ffffff;font-weight:800\"\u003eA sterility test without growth does not demonstrate sterility, growth promotion is not method suitability, endotoxins are not pyrogens: the microbiology laboratory governed with the source next to every value.\u003c\/h3\u003e\u003cp style=\"margin:0 0 20px 0;font-size:16px;color:#EFE6DA;max-width:700px\"\u003eA quality and technical guide for those who organise, perform, verify and govern the GMP QC microbiology laboratory, from sample to decision: organisation and personnel, sterility testing and isolators, bioburden and endotoxins, rapid methods and identification, media, strains and incubation, samples and samplers, equipment, microbiological OOS results and contract laboratories. \u003cstrong\u003e18 chapters in six parts\u003c\/strong\u003e and 6 appendices, 246 pages in the Italian edition and 248 in the English one, and \u003cstrong\u003e16 editable tools\u003c\/strong\u003e in Word and Excel, for €179.\u003c\/p\u003e\u003cdiv style=\"display:flex;flex-wrap:wrap;gap:9px\"\u003e\u003cspan style=\"background:#4A2F28;color:#EFE6DA;font-size:13px;padding:7px 13px;border-radius:20px\"\u003e246 pages (ITA) · 248 (ENG) · PDF A4\u003c\/span\u003e\u003cspan style=\"background:#4A2F28;color:#EFE6DA;font-size:13px;padding:7px 13px;border-radius:20px\"\u003e18 chapters in six parts + 6 appendices\u003c\/span\u003e\u003cspan style=\"background:#4A2F28;color:#EFE6DA;font-size:13px;padding:7px 13px;border-radius:20px\"\u003e16 tools: 8 Word + 8 Excel\u003c\/span\u003e\u003cspan style=\"background:#4A2F28;color:#EFE6DA;font-size:13px;padding:7px 13px;border-radius:20px\"\u003e99 sources in the register\u003c\/span\u003e\u003cspan style=\"background:#4A2F28;color:#EFE6DA;font-size:13px;padding:7px 13px;border-radius:20px\"\u003e91 tracked decisions\u003c\/span\u003e\u003cspan style=\"background:#4A2F28;color:#EFE6DA;font-size:13px;padding:7px 13px;border-radius:20px\"\u003eDigital product: download after payment\u003c\/span\u003e\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"background:#F7F1E6;border:1px solid #E6DCCD;border-left:4px solid #EC6FA9;border-radius:0 11px 11px 0;padding:16px 20px;margin-bottom:26px;font-size:14.5px;color:#33241F\"\u003e\u003cstrong style=\"color:#7A4A3A\"\u003eOne language per purchase, chosen by the variant.\u003c\/strong\u003e The \u003cstrong\u003eITA - Italiano\u003c\/strong\u003e variant gives you the PDF guide and the 16 tools in Italian; the \u003cstrong\u003eENG - English\u003c\/strong\u003e variant gives them in English. Both editions have the same structure, the same tools and the same codes MB-TK-01…16. There are no files in French, German or Spanish.\u003c\/div\u003e\u003cdiv\u003e\u003ch3 style=\"font-size:22px;margin:0 0 6px 0;color:#2B1E1A\"\u003eThe decisions it helps you make\u003c\/h3\u003e\u003cp style=\"margin:0 0 14px 0;font-size:15px;color:#5E4A40;max-width:720px\"\u003eEvery chapter starts from a laboratory decision and closes it with who decides, on what basis and where it is recorded: 91 decision codes, each linked to the tool where it is documented.\u003c\/p\u003e\u003cdiv style=\"display:flex;flex-wrap:wrap;gap:12px;margin-bottom:28px\"\u003e\u003cdiv style=\"flex:1 1 300px;background:#FFFFFF;border:1px solid #E6DCCD;border-top:3px solid #EC6FA9;border-radius:10px;padding:15px 17px\"\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eProgramme, reference texts and boundaries\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#33241F;margin-bottom:7px\"\u003eProgramme owner, reference texts per product and market, areas, flows and segregation, where the sterility test is performed and on which device cultures are handled.\u003c\/div\u003e\u003cdiv style=\"font-size:12.5px;font-weight:600;color:#7A4A3A\"\u003eChapters 1–2 · MB-TK-01\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 300px;background:#FFFFFF;border:1px solid #E6DCCD;border-top:3px solid #EC6FA9;border-radius:10px;padding:15px 17px\"\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003ePersonnel and aseptic technique\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#33241F;margin-bottom:7px\"\u003eWhich evidence authorises an analyst to perform a test, with observed assessment and a simulated test with medium, and when the authorisation must be renewed.\u003c\/div\u003e\u003cdiv style=\"font-size:12.5px;font-weight:600;color:#7A4A3A\"\u003eChapter 3 · MB-TK-02\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 300px;background:#FFFFFF;border:1px solid #E6DCCD;border-top:3px solid #EC6FA9;border-radius:10px;padding:15px 17px\"\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eSterility test method and suitability\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#33241F;margin-bottom:7px\"\u003eMembrane filtration or direct inoculation, sampling plan and suitability per product, knowing that the test does not demonstrate sterility.\u003c\/div\u003e\u003cdiv style=\"font-size:12.5px;font-weight:600;color:#7A4A3A\"\u003eChapter 4 · MB-TK-03\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 300px;background:#FFFFFF;border:1px solid #E6DCCD;border-top:3px solid #EC6FA9;border-radius:10px;padding:15px 17px\"\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eIsolator and bio-decontamination cycle\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#33241F;margin-bottom:7px\"\u003eIncoming BI population, log reduction by position, peroxide residue and media stasis, temperature-corrected leak test, glove tests.\u003c\/div\u003e\u003cdiv style=\"font-size:12.5px;font-weight:600;color:#7A4A3A\"\u003eChapter 5 · MB-TK-04\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 300px;background:#FFFFFF;border:1px solid #E6DCCD;border-top:3px solid #EC6FA9;border-radius:10px;padding:15px 17px\"\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003ePositive test: invalidation or batch rejection\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#33241F;margin-bottom:7px\"\u003eWith which evidence a positive can be attributed unequivocally to a laboratory error, who approves an invalidation and when the investigation moves to manufacturing and other batches.\u003c\/div\u003e\u003cdiv style=\"font-size:12.5px;font-weight:600;color:#7A4A3A\"\u003eChapter 6 · MB-TK-05\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 300px;background:#FFFFFF;border:1px solid #E6DCCD;border-top:3px solid #EC6FA9;border-radius:10px;padding:15px 17px\"\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eBioburden and enumeration\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#33241F;margin-bottom:7px\"\u003eMethod, quantity tested and neutralisation with recoveries and exact intervals, a declared counting convention, low or zero results and objectionable organisms.\u003c\/div\u003e\u003cdiv style=\"font-size:12.5px;font-weight:600;color:#7A4A3A\"\u003eChapter 7 · MB-TK-06\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 300px;background:#FFFFFF;border:1px solid #E6DCCD;border-top:3px solid #EC6FA9;border-radius:10px;padding:15px 17px\"\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eEndotoxins\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#33241F;margin-bottom:7px\"\u003eTechnique and reagent, MVD and routine dilution with the positive product control, a hold study on masking, the pyrogenicity strategy and the move to recombinant reagents.\u003c\/div\u003e\u003cdiv style=\"font-size:12.5px;font-weight:600;color:#7A4A3A\"\u003eChapter 8 · MB-TK-07\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 300px;background:#FFFFFF;border:1px solid #E6DCCD;border-top:3px solid #EC6FA9;border-radius:10px;padding:15px 17px\"\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eRapid methods, identification and colony counters\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#33241F;margin-bottom:7px\"\u003eCriteria set before testing: colony counter agreement with the manual count, qualification of the identification system and its library, non-inferiority and equivalence of the rapid method.\u003c\/div\u003e\u003cdiv style=\"font-size:12.5px;font-weight:600;color:#7A4A3A\"\u003eChapter 9 · MB-TK-08\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 300px;background:#FFFFFF;border:1px solid #E6DCCD;border-top:3px solid #EC6FA9;border-radius:10px;padding:15px 17px\"\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eMedia, growth promotion and strains\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#33241F;margin-bottom:7px\"\u003eA designated group including local isolates, a release rule after the outcome for every organism, change control of recipes, passages and traceability of cultures.\u003c\/div\u003e\u003cdiv style=\"font-size:12.5px;font-weight:600;color:#7A4A3A\"\u003eChapters 10–11 · MB-TK-09, MB-TK-10\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 300px;background:#FFFFFF;border:1px solid #E6DCCD;border-top:3px solid #EC6FA9;border-radius:10px;padding:15px 17px\"\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eIncubation and excursions\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#33241F;margin-bottom:7px\"\u003eConditions and load that make the result sensitive, the logger's logging interval and an impact assessment of every episode outside the range.\u003c\/div\u003e\u003cdiv style=\"font-size:12.5px;font-weight:600;color:#7A4A3A\"\u003eChapter 12 · MB-TK-11\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 300px;background:#FFFFFF;border:1px solid #E6DCCD;border-top:3px solid #EC6FA9;border-radius:10px;padding:15px 17px\"\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eSamples, samplers and EM data\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#33241F;margin-bottom:7px\"\u003eAcceptance and chain of custody, maximum time from sampling to testing, the real flow rate of air samplers, surface recovery, reading and transfer of EM results.\u003c\/div\u003e\u003cdiv style=\"font-size:12.5px;font-weight:600;color:#7A4A3A\"\u003eChapters 13–15 · MB-TK-12, MB-TK-13\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 300px;background:#FFFFFF;border:1px solid #E6DCCD;border-top:3px solid #EC6FA9;border-radius:10px;padding:15px 17px\"\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eEquipment, OOS results and contract laboratories\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#33241F;margin-bottom:7px\"\u003eQualification of autoclaves, cabinets and incubators; phases I and II of a microbiological OOS with CAPA and effectiveness; suitability of a contract laboratory and periodic review.\u003c\/div\u003e\u003cdiv style=\"font-size:12.5px;font-weight:600;color:#7A4A3A\"\u003eChapters 16–18 · MB-TK-14, MB-TK-15, MB-TK-16\u003c\/div\u003e\u003c\/div\u003e\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"margin-bottom:26px\"\u003e\u003ch3 style=\"font-size:22px;margin:0 0 8px 0;color:#2B1E1A\"\u003eThe myths it takes apart\u003c\/h3\u003e\u003cp style=\"margin:0 0 14px 0;font-size:15px;color:#5E4A40;max-width:720px\"\u003eStatements that circulate as \"requirements\" and that the sources write differently. For each one the guide gives the document, clause, nature and jurisdiction.\u003c\/p\u003e\u003cdiv style=\"font-size:15px;color:#33241F\"\u003e\u003cp style=\"margin:0 0 11px 0\"\u003e\u003cstrong style=\"color:#2B1E1A\"\u003e\"A sterility test without growth proves the batch is sterile.\"\u003c\/strong\u003e The test has statistical limitations that the sources state (EU GMP Annex 1, 10.5; Annex 17, 4.2). The example in the 2004 FDA guidance (XI.B): 20 units from a batch with 0.1% contaminated units have a 98% probability of passing the test; 0 positives out of 20 are compatible, at 95%, with rates up to 13.91% [DEMONSTRATION EXAMPLE] (Chapters 4 and 6).\u003c\/p\u003e\u003cp style=\"margin:0 0 11px 0\"\u003e\u003cstrong style=\"color:#2B1E1A\"\u003e\"Same species in the test and in the laboratory environment: the positive is invalidated.\"\u003c\/strong\u003e Under the 2004 FDA guidance (XI.C) a test is invalidated only for an unequivocal, documented laboratory error; when the evidence is inconclusive the batch is rejected and the investigation extends to manufacturing. The species demonstrates neither the strain nor the route; growth in one medium only is still a positive; the invalidation is approved by laboratory QA (Chapter 6, Case A).\u003c\/p\u003e\u003cp style=\"margin:0 0 11px 0\"\u003e\u003cstrong style=\"color:#2B1E1A\"\u003e\"Repeating the sterility test once is always allowed.\"\u003c\/strong\u003e A repeat after definitive attribution to an error is a regulatory requirement in the USA for licensed biologics (21 CFR 610.12(f)); for drugs the 2004 FDA guidance (XI.C) and 21 CFR 211.192 apply. The guide gives source and nature and does not present it as a rule where it is not one (Chapter 6).\u003c\/p\u003e\u003cp style=\"margin:0 0 11px 0\"\u003e\u003cstrong style=\"color:#2B1E1A\"\u003e\"If the medium passes growth promotion, the method is suitable.\"\u003c\/strong\u003e Method suitability, validation and verification are distinct levels (EU GMP Chapter 6, 6.15; Annex 15, 9.2) and the growth promotion test (GPT) of a media batch is none of the three (Annex 1, 10.9). A medium that grows the reference strains can fail on a local isolate (Chapters 4 and 10, Case D).\u003c\/p\u003e\u003cp style=\"margin:0 0 11px 0\"\u003e\u003cstrong style=\"color:#2B1E1A\"\u003e\"The endotoxin test covers pyrogenicity, and the rabbit test remains a Ph. Eur. option.\"\u003c\/strong\u003e LAL and recombinant reagents detect only Gram-negative endotoxins: using them as the only pyrogenicity control requires a risk assessment. Ph. Eur. 5.1.13 'Pyrogenicity' has been in force since 01\/07\/2025 and chapter 2.6.8 'Pyrogens' has been suppressed since 01\/01\/2026 (Chapter 8).\u003c\/p\u003e\u003cp style=\"margin:0 0 11px 0\"\u003e\u003cstrong style=\"color:#2B1E1A\"\u003e\"The regulations set incubation times and temperatures.\"\u003c\/strong\u003e No regulation sets a single value. Annex 1, 9.4, asks for EM programme conditions set by risk assessment, with no value; the 30–35 °C and 20–25 °C in the 2004 FDA guidance for EM are indications, not requirements, and site-specific studies diverge (Chapter 12).\u003c\/p\u003e\u003cp style=\"margin:0 0 11px 0\"\u003e\u003cstrong style=\"color:#2B1E1A\"\u003e\"Media recovery is sampling efficiency, and ISO 14698 is the reference standard.\"\u003c\/strong\u003e Annex 1, 9.29, asks for supporting data on the recovery efficiency of the sampling methods: the GPT of the plates shows that the medium supports growth, not how much the plate or swab removes from the surface. ISO 14698-1 and -2 were withdrawn on 16\/03\/2026 with no replacement indicated (Chapter 14).\u003c\/p\u003e\u003cp style=\"margin:0 0 11px 0\"\u003e\u003cstrong style=\"color:#2B1E1A\"\u003e\"A laminar flow clean bench is a biological safety cabinet, and bio-decontamination sterilises the isolator.\"\u003c\/strong\u003e Under the WHO Laboratory Biosafety Manual (4th edition, 2020) clean benches are not primary containment; under PIC\/S PI 014-3, 5.3, a sporicidal process applied to an isolator is not considered a sterilisation process (Chapters 5 and 16).\u003c\/p\u003e\u003cp style=\"margin:0 0 11px 0\"\u003e\u003cstrong style=\"color:#2B1E1A\"\u003e\"An ISO\/IEC 17025-accredited contract laboratory is qualified.\"\u003c\/strong\u003e Accreditation demonstrates competence within the accredited scope; EU GMP Chapter 7, 7.5, requires the contract giver to assess the \"legality, suitability and the competence\" of the laboratory for its own product. In Case E an external \"not detected\" retest hides a generic suitability test without a neutraliser (Chapter 18).\u003c\/p\u003e\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"display:flex;flex-wrap:wrap;gap:14px;margin-bottom:26px\"\u003e\u003cdiv style=\"flex:1 1 230px;background:#F7F1E6;border:1px solid #E6DCCD;border-top:3px solid #7A4A3A;border-radius:11px;padding:19px\"\u003e\u003cdiv style=\"font-size:12px;font-weight:700;color:#7A4A3A;letter-spacing:1.2px;text-transform:uppercase;margin-bottom:7px\"\u003eThe guide\u003c\/div\u003e\u003cdiv style=\"font-size:15px;color:#33241F\"\u003e18 chapters in six parts, named after the six themes of the Microbiology Laboratory and Sterility Testing hub, and 6 appendices. Chapters 2–18 follow seventeen fixed sections, always in the same order: \u003cstrong\u003erequirement → interpretation → risk → decision → action → evidence → audit readiness\u003c\/strong\u003e. Four status labels and seven nature labels tell you what each source is worth and in which jurisdiction.\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 230px;background:#F7F1E6;border:1px solid #E6DCCD;border-top:3px solid #7A4A3A;border-radius:11px;padding:19px\"\u003e\u003cdiv style=\"font-size:12px;font-weight:700;color:#7A4A3A;letter-spacing:1.2px;text-transform:uppercase;margin-bottom:7px\"\u003eThe toolkit\u003c\/div\u003e\u003cdiv style=\"font-size:15px;color:#33241F\"\u003e16 editable tools: 8 Word templates and 8 Excel workbooks, each as a clean template and as a filled-in example. The Excel workbooks have a Read_Me with the functional specification and the Formulas, Error_Check and Assumptions_Limits sheets, a \"Reason\" column next to every outcome, and return only \"Comparison with the entered criteria\" or \"Assessment required\".\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 230px;background:#F7F1E6;border:1px solid #E6DCCD;border-top:3px solid #7A4A3A;border-radius:11px;padding:19px\"\u003e\u003cdiv style=\"font-size:12px;font-weight:700;color:#7A4A3A;letter-spacing:1.2px;text-transform:uppercase;margin-bottom:7px\"\u003eFive integrated cases\u003c\/div\u003e\u003cdiv style=\"font-size:15px;color:#33241F\"\u003eIn the microbiology laboratory of the fictitious company Torvenza Pharma: a positive sterility test with the same species, a different strain and the batch rejected (Case A), cycle development for a testing isolator with a cold spot and a peroxide residue (B), the routine endotoxin dilution and masking over time, rFC included (C), growth promotion failing on a local isolate after the media batch was released (D), a count OOS on a non-sterile product with an external retest and a contract laboratory (E). The \"Questions\" sheet of MB-TK-16 holds 120 inspector questions.\u003c\/div\u003e\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"background:#F7F1E6;border-left:4px solid #7A4A3A;border-radius:0 11px 11px 0;padding:22px 24px;margin-bottom:30px\"\u003e\u003cdiv style=\"font-size:19px;font-weight:800;color:#7A4A3A;margin-bottom:10px\"\u003eRegulatory status verified as of 04\/10\/2026\u003c\/div\u003e\u003cp style=\"margin:0 0 11px 0;font-size:15px;color:#33241F\"\u003eThe guide describes the regulatory and technical framework as of \u003cstrong\u003e04\/10\/2026\u003c\/strong\u003e; documents published or amended after this date are not considered. Every source carries a status label (current, draft, in development, superseded) and a nature label, with the jurisdiction where it applies; texts published but not yet applicable carry no status label. The points that most often change the reading:\u003c\/p\u003e\u003cul style=\"margin:0 0 12px 0;padding-left:20px;font-size:15px;color:#33241F\"\u003e\u003cli style=\"margin:0 0 8px 0\"\u003e\u003cstrong\u003eEU GMP Annex 1 (2022)\u003c\/strong\u003e has been operational since 25\/08\/2023 and fully applicable, point 8.123 included, since 25\/08\/2024. The revised Annex 19 applies from 24\/09\/2026; PIC\/S PE 009-18 is in force from the same date.\u003c\/li\u003e\u003cli style=\"margin:0 0 8px 0\"\u003e\u003cstrong\u003ePyrogens in the Ph. Eur.:\u003c\/strong\u003e chapter 5.1.13 'Pyrogenicity' has been in force since 01\/07\/2025; chapter 2.6.8 'Pyrogens' has been suppressed since 01\/01\/2026. These are two distinct dates.\u003c\/li\u003e\u003cli style=\"margin:0 0 8px 0\"\u003e\u003cstrong\u003eEndotoxins with recombinant reagents:\u003c\/strong\u003e Ph. Eur. 2.6.32 is current until 31\/12\/2026; method G of 2.6.14 applies from 01\/01\/2027 (Issue 13.1, published, not yet applicable). USP 〈86〉 (May 2025) is official but not 'applicable'. The FDA Q\u0026amp;A 'Pyrogen and Endotoxins Testing' Edition 2 (March 2026, page current as of 18\/03\/2026) is current; Edition 1 of June 2012 is superseded.\u003c\/li\u003e\u003cli style=\"margin:0 0 8px 0\"\u003e\u003cstrong\u003ePharmacopoeias:\u003c\/strong\u003e Ph. Eur. 12th Edition up to Issue 12.3 and USP–NF 2026, Issue 5 (official from 01\/10\/2026) are applicable. Ph. Eur. 5.1.9 has been revised since 01\/01\/2026; the revision of 5.1.6 on alternative methods applies from 01\/04\/2027, and until then the previous text remains in force.\u003c\/li\u003e\u003cli style=\"margin:0 0 8px 0\"\u003e\u003cstrong\u003ePIC\/S PI 012-3 and PI 014-3\u003c\/strong\u003e (25\/09\/2007), on sterility testing and isolators, are guidance for inspectors, dated and not mandatory for industry: their values are reported only as historical guidance. The guideline for the microbiology laboratory is WHO TRS 961, Annex 2; TRS 1052, Annex 4 excludes it.\u003c\/li\u003e\u003cli style=\"margin:0 0 8px 0\"\u003e\u003cstrong\u003eTechnical standards:\u003c\/strong\u003e ISO 14698-1 and -2 have been withdrawn since 16\/03\/2026 with no replacement indicated; for biological safety cabinets the EN 12469:2025 series (parts 1, 2 and 5) and NSF\/ANSI 49-2026 apply, both voluntary standards.\u003c\/li\u003e\u003cli style=\"margin:0 0 8px 0\"\u003e\u003cstrong\u003eDrafts:\u003c\/strong\u003e the 2025 revisions of Annex 11, Chapter 4 and Chapter 1 are drafts whose consultation has closed; the revision of Annex 15 is in development, with a draft planned for December 2026; the Pharmacopeial Forum proposals for USP 〈1117〉, 〈1113〉 and 〈1085〉 are not current text.\u003c\/li\u003e\u003c\/ul\u003e\u003cp style=\"margin:0;font-size:15px;color:#33241F\"\u003e\u003cstrong\u003eUpdates included.\u003c\/strong\u003e Appendix F lists the events that trigger re-verification of the guide: Ph. Eur. Issues 13.1, 13.2 and 13.3, new USP–NF Issues, Pharmacopeial Forum proposals, final texts of the Annex 11, Chapter 4 and Chapter 1 revisions, the draft of the revised Annex 15, ISO and EN standards in development, the effects of the new EU pharmaceutical legislation, the status of Annex 1 in Great Britain and NSF\/ANSI 49-2026. When the texts change, you receive the revised guide and toolkit at no extra cost. The guide does not announce release dates for its own revisions: the revision on sale is shown on this page.\u003c\/p\u003e\u003c\/div\u003e\u003cdiv\u003e\u003ch3 style=\"font-size:22px;margin:0 0 6px 0;color:#2B1E1A\"\u003eThe 16 tools, in six groups\u003c\/h3\u003e\u003cp style=\"margin:0 0 18px 0;font-size:15px;color:#5E4A40;max-width:720px\"\u003eOne folder per part of the book, with the exact titles of the English edition. \u003cstrong\u003eNo operational value is preloaded\u003c\/strong\u003e: incubation times and temperatures, numbers of units and volumes to be tested, inocula, recovery and suitability criteria, growth promotion test criteria, numbers of passages, countable ranges, bioburden and endotoxin limits, routine dilutions, log reduction targets, peroxide residues and aeration times, maximum sample hold times, requalification and review frequencies, numbers of replicates and acceptance criteria remain \u0026lt;to be defined\u0026gt;, with the decision code.\u003c\/p\u003e\u003cdiv style=\"font-size:13px;font-weight:700;color:#7A4A3A;letter-spacing:1px;text-transform:uppercase;margin:0 0 9px 0\"\u003e01_Lab_Organisation · Laboratory Organisation\u003c\/div\u003e\u003cdiv style=\"display:flex;flex-wrap:wrap;gap:12px;margin-bottom:20px\"\u003e\u003cdiv style=\"flex:1 1 250px;background:#FFFFFF;border:1px solid #E6DCCD;border-radius:10px;padding:15px\"\u003e\u003cspan style=\"display:inline-block;background:#4A2F28;color:#fff;font-size:10px;font-weight:700;letter-spacing:1px;padding:3px 7px;border-radius:3px;margin-bottom:8px\"\u003eEXCEL\u003c\/span\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eMB-TK-01 · Laboratory Test, Workflow and Responsibility Matrix\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#5E4A40\"\u003eAreas, tests with reference text and owner, flows, R\/A\/C\/I roles, equipment, interfaces and boundaries with the sister guides; flags tests with no owner. It neither qualifies nor decides.\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 250px;background:#FFFFFF;border:1px solid #E6DCCD;border-radius:10px;padding:15px\"\u003e\u003cspan style=\"display:inline-block;background:#7A4A3A;color:#fff;font-size:10px;font-weight:700;letter-spacing:1px;padding:3px 7px;border-radius:3px;margin-bottom:8px\"\u003eWORD\u003c\/span\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eMB-TK-02 · Personnel and Aseptic Technique Qualification Programme\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#5E4A40\"\u003eInitial qualification, maintenance and requalification of analysts by activity: training, observed assessment, simulated test with medium, unfavourable outcomes.\u003c\/div\u003e\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"font-size:13px;font-weight:700;color:#7A4A3A;letter-spacing:1px;text-transform:uppercase;margin:0 0 9px 0\"\u003e02_Sterility_Isolators · Sterility Testing and Isolators\u003c\/div\u003e\u003cdiv style=\"display:flex;flex-wrap:wrap;gap:12px;margin-bottom:20px\"\u003e\u003cdiv style=\"flex:1 1 250px;background:#FFFFFF;border:1px solid #E6DCCD;border-radius:10px;padding:15px\"\u003e\u003cspan style=\"display:inline-block;background:#7A4A3A;color:#fff;font-size:10px;font-weight:700;letter-spacing:1px;padding:3px 7px;border-radius:3px;margin-bottom:8px\"\u003eWORD\u003c\/span\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eMB-TK-03 · Sterility Test Method Suitability Protocol\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#5E4A40\"\u003eProtocol and report per product: method, sampling plan, parameters, strains, environment, controls and the statistical limitations of the test; the growth criterion is that of the applied chapter.\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 250px;background:#FFFFFF;border:1px solid #E6DCCD;border-radius:10px;padding:15px\"\u003e\u003cspan style=\"display:inline-block;background:#4A2F28;color:#fff;font-size:10px;font-weight:700;letter-spacing:1px;padding:3px 7px;border-radius:3px;margin-bottom:8px\"\u003eEXCEL\u003c\/span\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eMB-TK-04 · Isolator Bio-decontamination Cycle Log and Analysis\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#5E4A40\"\u003eIncoming BIs, log reduction by position, D values, stasis against the chamber sensor, temperature-corrected leak test, glove tests.\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 250px;background:#FFFFFF;border:1px solid #E6DCCD;border-radius:10px;padding:15px\"\u003e\u003cspan style=\"display:inline-block;background:#7A4A3A;color:#fff;font-size:10px;font-weight:700;letter-spacing:1px;padding:3px 7px;border-radius:3px;margin-bottom:8px\"\u003eWORD\u003c\/span\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eMB-TK-05 · Positive Sterility Test Investigation Form\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#5E4A40\"\u003eFrom reading to decision: session controls, identification and typing, laboratory and manufacturing hypotheses, extension to other batches; no automatic invalidation criterion.\u003c\/div\u003e\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"font-size:13px;font-weight:700;color:#7A4A3A;letter-spacing:1px;text-transform:uppercase;margin:0 0 9px 0\"\u003e03_Methods_Technologies · Microbiological Methods and Technologies\u003c\/div\u003e\u003cdiv style=\"display:flex;flex-wrap:wrap;gap:12px;margin-bottom:20px\"\u003e\u003cdiv style=\"flex:1 1 250px;background:#FFFFFF;border:1px solid #E6DCCD;border-radius:10px;padding:15px\"\u003e\u003cspan style=\"display:inline-block;background:#4A2F28;color:#fff;font-size:10px;font-weight:700;letter-spacing:1px;padding:3px 7px;border-radius:3px;margin-bottom:8px\"\u003eEXCEL\u003c\/span\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eMB-TK-06 · Enumeration, Recovery and Method Suitability Calculator (Poisson, MPN)\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#5E4A40\"\u003eConcentrations with the declared convention, exact Poisson intervals, index of dispersion, MPN, recoveries and neutralisation with CIs, survival study.\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 250px;background:#FFFFFF;border:1px solid #E6DCCD;border-radius:10px;padding:15px\"\u003e\u003cspan style=\"display:inline-block;background:#4A2F28;color:#fff;font-size:10px;font-weight:700;letter-spacing:1px;padding:3px 7px;border-radius:3px;margin-bottom:8px\"\u003eEXCEL\u003c\/span\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eMB-TK-07 · Endotoxin Calculator (MVD, Dilutions, Positive Product Control, Interference)\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#5E4A40\"\u003eMVD and dilutions, composite samples, PPC recovery and margin by dilution, percentage of the limit, hold studies and retrospective assessment; it does not choose the routine dilution.\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 250px;background:#FFFFFF;border:1px solid #E6DCCD;border-radius:10px;padding:15px\"\u003e\u003cspan style=\"display:inline-block;background:#7A4A3A;color:#fff;font-size:10px;font-weight:700;letter-spacing:1px;padding:3px 7px;border-radius:3px;margin-bottom:8px\"\u003eWORD\u003c\/span\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eMB-TK-08 · Rapid Method, Identification System and Colony Counter Evaluation Protocol\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#5E4A40\"\u003eThree evaluations with criteria set in advance: colony counter agreement, qualification of the identification system and its library, non-inferiority and equivalence of the rapid method.\u003c\/div\u003e\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"font-size:13px;font-weight:700;color:#7A4A3A;letter-spacing:1px;text-transform:uppercase;margin:0 0 9px 0\"\u003e04_Media_Strains_Incubation · Media, Strains and Incubation\u003c\/div\u003e\u003cdiv style=\"display:flex;flex-wrap:wrap;gap:12px;margin-bottom:20px\"\u003e\u003cdiv style=\"flex:1 1 250px;background:#FFFFFF;border:1px solid #E6DCCD;border-radius:10px;padding:15px\"\u003e\u003cspan style=\"display:inline-block;background:#4A2F28;color:#fff;font-size:10px;font-weight:700;letter-spacing:1px;padding:3px 7px;border-radius:3px;margin-bottom:8px\"\u003eEXCEL\u003c\/span\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eMB-TK-09 · Culture Media Batch and Growth Promotion Register\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#5E4A40\"\u003eBatches, preparation, designated group, GPT by organism with ratio and exact CI, release rule; flags a batch released before the outcome for every organism.\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 250px;background:#FFFFFF;border:1px solid #E6DCCD;border-radius:10px;padding:15px\"\u003e\u003cspan style=\"display:inline-block;background:#7A4A3A;color:#fff;font-size:10px;font-weight:700;letter-spacing:1px;padding:3px 7px;border-radius:3px;margin-bottom:8px\"\u003eWORD\u003c\/span\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eMB-TK-10 · Reference Strain Management Model Procedure\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#5E4A40\"\u003eProcurement, seed lots, working cultures with passage count, purity and identity, local isolates, storage deviations.\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 250px;background:#FFFFFF;border:1px solid #E6DCCD;border-radius:10px;padding:15px\"\u003e\u003cspan style=\"display:inline-block;background:#4A2F28;color:#fff;font-size:10px;font-weight:700;letter-spacing:1px;padding:3px 7px;border-radius:3px;margin-bottom:8px\"\u003eEXCEL\u003c\/span\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eMB-TK-11 · Incubation Excursion Calculator\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#5E4A40\"\u003eFrom the logger series: episodes outside the range, duration, extreme value, area outside the limit, effect of the logging interval, impact assessment by episode.\u003c\/div\u003e\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"font-size:13px;font-weight:700;color:#7A4A3A;letter-spacing:1px;text-transform:uppercase;margin:0 0 9px 0\"\u003e05_Sampling_Samples · Sampling and Sample Management\u003c\/div\u003e\u003cdiv style=\"display:flex;flex-wrap:wrap;gap:12px;margin-bottom:20px\"\u003e\u003cdiv style=\"flex:1 1 250px;background:#FFFFFF;border:1px solid #E6DCCD;border-radius:10px;padding:15px\"\u003e\u003cspan style=\"display:inline-block;background:#7A4A3A;color:#fff;font-size:10px;font-weight:700;letter-spacing:1px;padding:3px 7px;border-radius:3px;margin-bottom:8px\"\u003eWORD\u003c\/span\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eMB-TK-12 · Sample Receipt, Chain of Custody and Hold Time Checklist\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#5E4A40\"\u003eAcceptance, chain of custody, time from sampling to testing against the decided maximum, storage while awaiting testing, shipments to a contract laboratory.\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 250px;background:#FFFFFF;border:1px solid #E6DCCD;border-radius:10px;padding:15px\"\u003e\u003cspan style=\"display:inline-block;background:#4A2F28;color:#fff;font-size:10px;font-weight:700;letter-spacing:1px;padding:3px 7px;border-radius:3px;margin-bottom:8px\"\u003eEXCEL\u003c\/span\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eMB-TK-13 · Air Sampler and Surface Recovery Calculator\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#5E4A40\"\u003eFlow rate verification, effect of flow rate error, positive-hole correction, Stokes d₅₀, surface recovery with exact CI; EM sites and limits stay with the programme.\u003c\/div\u003e\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"font-size:13px;font-weight:700;color:#7A4A3A;letter-spacing:1px;text-transform:uppercase;margin:0 0 9px 0\"\u003e06_Equipment_Reliability · Equipment and Result Reliability\u003c\/div\u003e\u003cdiv style=\"display:flex;flex-wrap:wrap;gap:12px;margin-bottom:20px\"\u003e\u003cdiv style=\"flex:1 1 250px;background:#FFFFFF;border:1px solid #E6DCCD;border-radius:10px;padding:15px\"\u003e\u003cspan style=\"display:inline-block;background:#7A4A3A;color:#fff;font-size:10px;font-weight:700;letter-spacing:1px;padding:3px 7px;border-radius:3px;margin-bottom:8px\"\u003eWORD\u003c\/span\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eMB-TK-14 · Laboratory Autoclave, Biosafety Cabinet and Incubator Qualification Protocol\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#5E4A40\"\u003eIQ, OQ, PQ and requalification for defined loads, cabinets and clean benches, incubators; routine checks, out of service and return to service.\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 250px;background:#FFFFFF;border:1px solid #E6DCCD;border-radius:10px;padding:15px\"\u003e\u003cspan style=\"display:inline-block;background:#7A4A3A;color:#fff;font-size:10px;font-weight:700;letter-spacing:1px;padding:3px 7px;border-radius:3px;margin-bottom:8px\"\u003eWORD\u003c\/span\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eMB-TK-15 · Microbiological OOS Investigation and CAPA Form\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#5E4A40\"\u003ePhase I, consistency of the counts, objectionables, discriminating tests, retests and resampling, extension to manufacturing, contract laboratory, CAPA and effectiveness.\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 250px;background:#FFFFFF;border:1px solid #E6DCCD;border-radius:10px;padding:15px\"\u003e\u003cspan style=\"display:inline-block;background:#4A2F28;color:#fff;font-size:10px;font-weight:700;letter-spacing:1px;padding:3px 7px;border-radius:3px;margin-bottom:8px\"\u003eEXCEL\u003c\/span\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:5px\"\u003eMB-TK-16 · Contract Laboratory Assessment and Periodic Review\u003c\/div\u003e\u003cdiv style=\"font-size:14px;color:#5E4A40\"\u003eContract, audits, completeness of external results; indicators, negative control trending, checklist, inspector questions and source review. Accreditation alone does not qualify a laboratory.\u003c\/div\u003e\u003c\/div\u003e\u003c\/div\u003e\u003cp style=\"margin:0 0 28px 0;font-size:14px;color:#5E4A40\"\u003eIn the ITA - Italiano variant the same 16 tools carry the titles of the Italian edition and the same codes MB-TK-01…16. Every tool also exists as a filled-in example on the Torvenza Pharma case, in the 07_Examples folder.\u003c\/p\u003e\u003c\/div\u003e\u003cdiv\u003e\u003ch3 style=\"font-size:22px;margin:0 0 14px 0;color:#2B1E1A\"\u003eReady to use tomorrow morning\u003c\/h3\u003e\u003ctable style=\"width:100%;border-collapse:collapse;font-size:14.5px;margin-bottom:28px\"\u003e\u003ctr style=\"background:#2B1E1A;color:#fff\"\u003e\u003cth style=\"text-align:left;padding:11px 13px\"\u003eThe situation\u003c\/th\u003e\u003cth style=\"text-align:left;padding:11px 13px\"\u003eWhat you use\u003c\/th\u003e\u003c\/tr\u003e\u003ctr style=\"background:#F7F1E6\"\u003e\u003ctd style=\"padding:11px 13px;border-bottom:1px solid #E6DCCD;vertical-align:top;width:38%\"\u003eA new product to bring into sterility testing\u003c\/td\u003e\u003ctd style=\"padding:11px 13px;border-bottom:1px solid #E6DCCD;vertical-align:top\"\u003eChapter 4 + MB-TK-03: choice between membrane filtration and direct inoculation, sampling plan, suitability per product with the criterion of the applied chapter and stated statistical limitations.\u003c\/td\u003e\u003c\/tr\u003e\u003ctr style=\"\"\u003e\u003ctd style=\"padding:11px 13px;border-bottom:1px solid #E6DCCD;vertical-align:top;width:38%\"\u003eA turbid canister and a proposal to invalidate the test\u003c\/td\u003e\u003ctd style=\"padding:11px 13px;border-bottom:1px solid #E6DCCD;vertical-align:top\"\u003eChapter 6 + MB-TK-05: session controls, identification and typing, hypothesis matrix, laboratory QA decision and extension to other batches. It is Case A.\u003c\/td\u003e\u003c\/tr\u003e\u003ctr style=\"background:#F7F1E6\"\u003e\u003ctd style=\"padding:11px 13px;border-bottom:1px solid #E6DCCD;vertical-align:top;width:38%\"\u003eA new testing isolator or a bio-decontamination cycle to develop\u003c\/td\u003e\u003ctd style=\"padding:11px 13px;border-bottom:1px solid #E6DCCD;vertical-align:top\"\u003eChapter 5 + MB-TK-04: incoming BIs, log reduction by position, aeration justified by the stasis test, temperature-corrected leak test. It is Case B.\u003c\/td\u003e\u003c\/tr\u003e\u003ctr style=\"\"\u003e\u003ctd style=\"padding:11px 13px;border-bottom:1px solid #E6DCCD;vertical-align:top;width:38%\"\u003eA formulation with chelating agents and surfactants, or the move from LAL to rFC\u003c\/td\u003e\u003ctd style=\"padding:11px 13px;border-bottom:1px solid #E6DCCD;vertical-align:top\"\u003eChapters 8 and 13 + MB-TK-07 and MB-TK-12: interference screening, routine dilution, hold study, maximum sample hold time, retrospective assessment of released batches. It is Case C.\u003c\/td\u003e\u003c\/tr\u003e\u003ctr style=\"background:#F7F1E6\"\u003e\u003ctd style=\"padding:11px 13px;border-bottom:1px solid #E6DCCD;vertical-align:top;width:38%\"\u003eA released media batch that fails GPT on a local isolate\u003c\/td\u003e\u003ctd style=\"padding:11px 13px;border-bottom:1px solid #E6DCCD;vertical-align:top\"\u003eChapters 10 and 11 + MB-TK-09 and MB-TK-10: designated group, release rule, cause test, change control of the recipe, impact on the readings of the batch. It is Case D.\u003c\/td\u003e\u003c\/tr\u003e\u003ctr style=\"\"\u003e\u003ctd style=\"padding:11px 13px;border-bottom:1px solid #E6DCCD;vertical-align:top;width:38%\"\u003eAn out-of-specification count on a non-sterile product and an external \"not detected\" retest\u003c\/td\u003e\u003ctd style=\"padding:11px 13px;border-bottom:1px solid #E6DCCD;vertical-align:top\"\u003eChapters 7, 13, 17 and 18 + MB-TK-06, MB-TK-12, MB-TK-15 and MB-TK-16: phase I, decay during the hold, objectionables, review of the contract laboratory's raw data. It is Case E.\u003c\/td\u003e\u003c\/tr\u003e\u003ctr style=\"background:#F7F1E6\"\u003e\u003ctd style=\"padding:11px 13px;border-bottom:1px solid #E6DCCD;vertical-align:top;width:38%\"\u003eA temperature excursion in an incubator\u003c\/td\u003e\u003ctd style=\"padding:11px 13px;border-bottom:1px solid #E6DCCD;vertical-align:top\"\u003eChapters 12 and 16 + MB-TK-11 and MB-TK-14: episodes from the logger series, effect of the logging interval, impact assessment by episode, out of service and return to service.\u003c\/td\u003e\u003c\/tr\u003e\u003ctr style=\"\"\u003e\u003ctd style=\"padding:11px 13px;border-bottom:1px solid #E6DCCD;vertical-align:top;width:38%\"\u003eA GMP inspection with the microbiology laboratory in scope\u003c\/td\u003e\u003ctd style=\"padding:11px 13px;border-bottom:1px solid #E6DCCD;vertical-align:top\"\u003eChapters 1, 2 and 18 + MB-TK-01 and MB-TK-16: tests with owners, flows and boundaries, periodic review, 120 inspector questions and 186 checklist rows built for training.\u003c\/td\u003e\u003c\/tr\u003e\u003c\/table\u003e\u003c\/div\u003e\u003cdiv style=\"background:#F7F1E6;border-left:4px solid #EC6FA9;border-radius:0 9px 9px 0;padding:20px 22px 9px 22px;margin-bottom:28px\"\u003e\u003cdiv style=\"font-weight:700;color:#2B1E1A;font-size:16px;margin-bottom:11px\"\u003eWhat the guide does not do\u003c\/div\u003e\u003cdiv style=\"font-size:14.5px;color:#33241F\"\u003e\u003cp style=\"margin:0 0 11px 0\"\u003e\u003cstrong style=\"color:#7A4A3A\"\u003eIt gives no universal numbers.\u003c\/strong\u003e No universal values for incubation times and temperatures, recoveries, GPT criteria, dilutions, numbers of units, replicates, passages or frequencies. Where a source states a value, the guide reports it with document, clause, nature and context; numerical examples are marked [DEMONSTRATION EXAMPLE].\u003c\/p\u003e\u003cp style=\"margin:0 0 11px 0\"\u003e\u003cstrong style=\"color:#7A4A3A\"\u003eIt never declares a method suitable or a result valid.\u003c\/strong\u003e No tool in the toolkit returns a favourable outcome: the only outcomes are \"Comparison with the entered criteria\" or \"Assessment required\", and missing data always lead to the latter. The decision on a result, a media batch, an item of equipment or an investigation rests with the quality function, on the basis of data and a documented assessment.\u003c\/p\u003e\u003cp style=\"margin:0 0 11px 0\"\u003e\u003cstrong style=\"color:#7A4A3A\"\u003eIt does not duplicate the sister guides.\u003c\/strong\u003e Sites, frequencies, limits and trends of the environmental monitoring programme are in the \u003ca href=\"https:\/\/www.guidegxp.com\/products\/guida-environmental-monitoring-gmp\" style=\"color:#7A4A3A;font-weight:700\"\u003e\"Operational Guide to Environmental Monitoring Systems in GMP Facilities\"\u003c\/a\u003e; Annex 1 as a whole in \u003ca href=\"https:\/\/www.guidegxp.com\/products\/guida-operativa-all-implementazione-dell-annex-1-eu-gmp-rev-2022\" style=\"color:#7A4A3A;font-weight:700\"\u003e\"EU GMP Annex 1 (2022): The Complete Map — GuideGxP Operational Guide\"\u003c\/a\u003e; design and criteria of the aseptic process simulation in \u003ca href=\"https:\/\/www.guidegxp.com\/products\/aseptic-process-simulation-media-fill-guida-pratica-secondo-annex-1-eu-gmp\" style=\"color:#7A4A3A;font-weight:700\"\u003e\"Aseptic Process Simulation (Media Fill): Designing, Running and Defending the APS under Annex 1 and FDA\"\u003c\/a\u003e; general instrument qualification in the \u003ca href=\"https:\/\/www.guidegxp.com\/products\/analytical-instrumentation-gmp-qc-laboratory-guide\" style=\"color:#7A4A3A;font-weight:700\"\u003e\"Operational Guide to Analytical Instrumentation in the GMP QC Laboratory (First Edition + Toolkit)\"\u003c\/a\u003e; data governance and audit trail review in \u003ca href=\"https:\/\/www.guidegxp.com\/products\/data-integrity-gmp-guida-operativa-audit-trail-review\" style=\"color:#7A4A3A;font-weight:700\"\u003e\"Data Integrity in GMP – Operational Guide to Governance, Audit Trail Review and QC Laboratories\"\u003c\/a\u003e. This guide covers the laboratory side and how it connects to those requirements.\u003c\/p\u003e\u003cp style=\"margin:0 0 11px 0\"\u003e\u003cstrong style=\"color:#7A4A3A\"\u003eIt is not legal advice and does not reproduce subscription texts.\u003c\/strong\u003e It describes the texts, status and force of the sources. USP–NF, Ph. Eur., JP, ISO, EN, NSF\/ANSI and PDA are cited by title, number, edition and status, with no content, tables or numerical criteria; Ph. Eur. texts are reported from official EDQM sources, without direct consultation.\u003c\/p\u003e\u003c\/div\u003e\u003c\/div\u003e\u003cdiv\u003e\u003ch3 style=\"font-size:22px;margin:0 0 6px 0;color:#2B1E1A\"\u003eContents: six parts, 18 chapters\u003c\/h3\u003e\u003cp style=\"margin:0 0 14px 0;font-size:15px;color:#5E4A40;max-width:720px\"\u003eChapter titles of the English edition. Every chapter closes with a checklist, related tools and articles, decisions and the chapter's sources.\u003c\/p\u003e\u003cdiv style=\"display:flex;flex-wrap:wrap;gap:12px;margin-bottom:14px\"\u003e\u003cdiv style=\"flex:1 1 300px;background:#FFFFFF;border:1px solid #E6DCCD;border-radius:10px;padding:15px 17px\"\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:7px\"\u003ePart I — Laboratory Organisation\u003c\/div\u003e\u003col style=\"margin:0;padding-left:0;list-style:none;font-size:14px;color:#33241F\"\u003e\u003cli style=\"margin:0 0 4px 0\"\u003e\u003cspan style=\"color:#7A4A3A;font-weight:700\"\u003e1.\u003c\/span\u003e Regulatory basis, responsibilities and governance of the microbiology laboratory\u003c\/li\u003e\u003cli style=\"margin:0 0 4px 0\"\u003e\u003cspan style=\"color:#7A4A3A;font-weight:700\"\u003e2.\u003c\/span\u003e Organisation, workflows, premises and segregation\u003c\/li\u003e\u003cli style=\"margin:0 0 4px 0\"\u003e\u003cspan style=\"color:#7A4A3A;font-weight:700\"\u003e3.\u003c\/span\u003e Personnel: qualification, aseptic technique and competence\u003c\/li\u003e\u003c\/ol\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 300px;background:#FFFFFF;border:1px solid #E6DCCD;border-radius:10px;padding:15px 17px\"\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:7px\"\u003ePart II — Sterility Testing and Isolators\u003c\/div\u003e\u003col style=\"margin:0;padding-left:0;list-style:none;font-size:14px;color:#33241F\"\u003e\u003cli style=\"margin:0 0 4px 0\"\u003e\u003cspan style=\"color:#7A4A3A;font-weight:700\"\u003e4.\u003c\/span\u003e Sterility test method: membrane filtration, direct inoculation, method suitability\u003c\/li\u003e\u003cli style=\"margin:0 0 4px 0\"\u003e\u003cspan style=\"color:#7A4A3A;font-weight:700\"\u003e5.\u003c\/span\u003e Isolators for sterility testing and bio-decontamination\u003c\/li\u003e\u003cli style=\"margin:0 0 4px 0\"\u003e\u003cspan style=\"color:#7A4A3A;font-weight:700\"\u003e6.\u003c\/span\u003e Execution, aseptic controls and investigation of the positive test\u003c\/li\u003e\u003c\/ol\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 300px;background:#FFFFFF;border:1px solid #E6DCCD;border-radius:10px;padding:15px 17px\"\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:7px\"\u003ePart III — Microbiological Methods and Technologies\u003c\/div\u003e\u003col style=\"margin:0;padding-left:0;list-style:none;font-size:14px;color:#33241F\"\u003e\u003cli style=\"margin:0 0 4px 0\"\u003e\u003cspan style=\"color:#7A4A3A;font-weight:700\"\u003e7.\u003c\/span\u003e Bioburden and enumeration: recovery and suitability\u003c\/li\u003e\u003cli style=\"margin:0 0 4px 0\"\u003e\u003cspan style=\"color:#7A4A3A;font-weight:700\"\u003e8.\u003c\/span\u003e Endotoxins: methods, recombinant reagents, interference\u003c\/li\u003e\u003cli style=\"margin:0 0 4px 0\"\u003e\u003cspan style=\"color:#7A4A3A;font-weight:700\"\u003e9.\u003c\/span\u003e Rapid methods, microbial identification and colony counters\u003c\/li\u003e\u003c\/ol\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 300px;background:#FFFFFF;border:1px solid #E6DCCD;border-radius:10px;padding:15px 17px\"\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:7px\"\u003ePart IV — Media, Strains and Incubation\u003c\/div\u003e\u003col style=\"margin:0;padding-left:0;list-style:none;font-size:14px;color:#33241F\"\u003e\u003cli style=\"margin:0 0 4px 0\"\u003e\u003cspan style=\"color:#7A4A3A;font-weight:700\"\u003e10.\u003c\/span\u003e Culture media: preparation, sterilisation, storage and growth promotion\u003c\/li\u003e\u003cli style=\"margin:0 0 4px 0\"\u003e\u003cspan style=\"color:#7A4A3A;font-weight:700\"\u003e11.\u003c\/span\u003e Reference strains: traceability and management\u003c\/li\u003e\u003cli style=\"margin:0 0 4px 0\"\u003e\u003cspan style=\"color:#7A4A3A;font-weight:700\"\u003e12.\u003c\/span\u003e Incubation: conditions, times and excursions\u003c\/li\u003e\u003c\/ol\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 300px;background:#FFFFFF;border:1px solid #E6DCCD;border-radius:10px;padding:15px 17px\"\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:7px\"\u003ePart V — Sampling and Sample Management\u003c\/div\u003e\u003col style=\"margin:0;padding-left:0;list-style:none;font-size:14px;color:#33241F\"\u003e\u003cli style=\"margin:0 0 4px 0\"\u003e\u003cspan style=\"color:#7A4A3A;font-weight:700\"\u003e13.\u003c\/span\u003e Samples: receipt, chain of custody and timing\u003c\/li\u003e\u003cli style=\"margin:0 0 4px 0\"\u003e\u003cspan style=\"color:#7A4A3A;font-weight:700\"\u003e14.\u003c\/span\u003e Air samplers and surface recovery (laboratory side)\u003c\/li\u003e\u003cli style=\"margin:0 0 4px 0\"\u003e\u003cspan style=\"color:#7A4A3A;font-weight:700\"\u003e15.\u003c\/span\u003e EM samples: incubation, reading, counting and data (interface with the EM programme)\u003c\/li\u003e\u003c\/ol\u003e\u003c\/div\u003e\u003cdiv style=\"flex:1 1 300px;background:#FFFFFF;border:1px solid #E6DCCD;border-radius:10px;padding:15px 17px\"\u003e\u003cdiv style=\"font-weight:700;font-size:15px;color:#2B1E1A;margin-bottom:7px\"\u003ePart VI — Equipment and Result Reliability\u003c\/div\u003e\u003col style=\"margin:0;padding-left:0;list-style:none;font-size:14px;color:#33241F\"\u003e\u003cli style=\"margin:0 0 4px 0\"\u003e\u003cspan style=\"color:#7A4A3A;font-weight:700\"\u003e16.\u003c\/span\u003e Laboratory autoclaves, biological safety cabinets and clean benches, incubators\u003c\/li\u003e\u003cli style=\"margin:0 0 4px 0\"\u003e\u003cspan style=\"color:#7A4A3A;font-weight:700\"\u003e17.\u003c\/span\u003e Microbiological OOS results, investigation and CAPA\u003c\/li\u003e\u003cli style=\"margin:0 0 4px 0\"\u003e\u003cspan style=\"color:#7A4A3A;font-weight:700\"\u003e18.\u003c\/span\u003e Contract laboratories, data integrity of microbiological data and periodic review\u003c\/li\u003e\u003c\/ol\u003e\u003c\/div\u003e\u003c\/div\u003e\u003cp style=\"margin:0 0 28px 0;font-size:14.5px;color:#33241F\"\u003e\u003cstrong style=\"color:#2B1E1A\"\u003eAppendices A–F.\u003c\/strong\u003e A ITA\/ENG glossary · B Source matrix · C Chapter, toolkit and article matrix · D Toolkit instructions · E Register of assumptions and limitations · F Revision and change log.\u003c\/p\u003e\u003c\/div\u003e\u003cdiv\u003e\u003ch3 style=\"font-size:22px;margin:0 0 6px 0;color:#2B1E1A\"\u003eWhat the package contains\u003c\/h3\u003e\u003cp style=\"margin:0 0 12px 0;font-size:15px;color:#5E4A40;max-width:720px\"\u003eAfter payment you download a ZIP file with the guide and the toolkit in the language of the chosen variant.\u003c\/p\u003e\u003cul style=\"margin:0 0 28px 0;padding-left:20px;font-size:15px;color:#33241F\"\u003e\u003cli style=\"margin:0 0 8px 0\"\u003e\u003cstrong style=\"color:#2B1E1A\"\u003eThe complete PDF guide.\u003c\/strong\u003e 246 A4 pages in the Italian edition, 248 in the English one; clickable table of contents and bookmarks.\u003c\/li\u003e\u003cli style=\"margin:0 0 8px 0\"\u003e\u003cstrong style=\"color:#2B1E1A\"\u003e16 editable tools.\u003c\/strong\u003e 8 Word templates and 8 Excel workbooks, in the folders 01_Lab_Organisation…06_Equipment_Reliability.\u003c\/li\u003e\u003cli style=\"margin:0 0 8px 0\"\u003e\u003cstrong style=\"color:#2B1E1A\"\u003e16 filled-in examples and demonstration datasets.\u003c\/strong\u003e The examples on the Torvenza Pharma case in the 07_Examples folder, with the datasets DS-01…DS-11 (laboratory, isolator cycles, counts and suitability, endotoxins, growth promotion, incubator logger, air sampler, test cases, colony counter, rapid method, contract laboratory) in .csv and .xlsx.\u003c\/li\u003e\u003cli style=\"margin:0 0 8px 0\"\u003e\u003cstrong style=\"color:#2B1E1A\"\u003eSupport files.\u003c\/strong\u003e README, toolkit index, field glossary and chapter–toolkit–article matrix in the 00_Read_Me folder.\u003c\/li\u003e\u003cli style=\"margin:0 0 8px 0\"\u003e\u003cstrong style=\"color:#2B1E1A\"\u003eVerification.\u003c\/strong\u003e Test Log with one row per tool, test case and file, language parity report, check of example values and a manifest with the SHA-256 hash of every file, in the 08_Verification folder.\u003c\/li\u003e\u003c\/ul\u003e\u003c\/div\u003e\u003cdiv style=\"background:#F7F1E6;border:1px solid #E6DCCD;border-radius:12px;padding:22px 24px;margin-bottom:28px\"\u003e\u003ch3 style=\"font-size:22px;margin:0 0 8px 0;color:#2B1E1A\"\u003eRead the excerpt before you buy\u003c\/h3\u003e\u003cp style=\"margin:0 0 16px 0;font-size:15px;color:#5E4A40;max-width:720px\"\u003eThe free excerpt is made of real pages: 16 pages in the Italian edition, 16 in the English one. It contains the presentation with the regulatory and technical status box and the labels, the full table of contents, from Chapter 4 what the sterility test can demonstrate, membrane filtration and direct inoculation, suitability, validation and verification, from Chapter 6 the invalidation of a positive test and the complete Case A, real pages of three tools (MB-TK-07, MB-TK-04 and MB-TK-05) and the list of what the purchase includes.\u003c\/p\u003e\u003cdiv style=\"display:flex;flex-wrap:wrap;gap:10px\"\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/GuideGxP_Microbiology_Lab_Preview_IT_v1.0.pdf?v=1791188414\" target=\"_blank\" rel=\"noopener\" hreflang=\"it\" style=\"display:inline-block;background:#2B1E1A;color:#ffffff;font-weight:700;font-size:15px;text-decoration:none;padding:12px 22px;border-radius:6px\"\u003eFree excerpt — Italian edition (PDF)\u003c\/a\u003e\u003ca href=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/GuideGxP_Microbiology_Lab_Preview_EN_v1.0.pdf?v=1791188414\" target=\"_blank\" rel=\"noopener\" hreflang=\"en\" style=\"display:inline-block;background:#ffffff;color:#2B1E1A;border:1.5px solid #2B1E1A;font-weight:700;font-size:15px;text-decoration:none;padding:11px 21px;border-radius:6px\"\u003eFree excerpt — English edition (PDF)\u003c\/a\u003e\u003c\/div\u003e\u003c\/div\u003e\u003cdiv\u003e\u003ch3 style=\"font-size:22px;margin:0 0 14px 0;color:#2B1E1A\"\u003eSpecifications\u003c\/h3\u003e\u003ctable style=\"width:100%;border-collapse:collapse;font-size:14.5px;margin-bottom:24px\"\u003e\u003ctr style=\"background:#F7F1E6\"\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD;width:32%;font-weight:600;color:#2B1E1A;vertical-align:top\"\u003eFormat\u003c\/td\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD\"\u003eA4 PDF with clickable table of contents and bookmarks; tools in .docx and .xlsx\u003c\/td\u003e\u003c\/tr\u003e\u003ctr style=\"\"\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD;width:32%;font-weight:600;color:#2B1E1A;vertical-align:top\"\u003ePages and chapters\u003c\/td\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD\"\u003e246 pages (ITA edition) · 248 pages (ENG edition) · 18 chapters in six parts + 6 appendices (A–F)\u003c\/td\u003e\u003c\/tr\u003e\u003ctr style=\"background:#F7F1E6\"\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD;width:32%;font-weight:600;color:#2B1E1A;vertical-align:top\"\u003eToolkit\u003c\/td\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD\"\u003e16 editable tools: 8 Word + 8 Excel, codes MB-TK-01…16, plus 16 filled-in examples\u003c\/td\u003e\u003c\/tr\u003e\u003ctr style=\"\"\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD;width:32%;font-weight:600;color:#2B1E1A;vertical-align:top\"\u003eFile languages\u003c\/td\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD\"\u003eOne language per purchase: \u003cstrong\u003eITA - Italiano\u003c\/strong\u003e or \u003cstrong\u003eENG - English\u003c\/strong\u003e. There are no files in French, German or Spanish.\u003c\/td\u003e\u003c\/tr\u003e\u003ctr style=\"background:#F7F1E6\"\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD;width:32%;font-weight:600;color:#2B1E1A;vertical-align:top\"\u003eEdition and revision\u003c\/td\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD\"\u003eFirst edition, October 2026 · v1.0 · tools v1.0\u003c\/td\u003e\u003c\/tr\u003e\u003ctr style=\"\"\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD;width:32%;font-weight:600;color:#2B1E1A;vertical-align:top\"\u003eRegulatory verification\u003c\/td\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD\"\u003e04\/10\/2026 (status of every source as of that date)\u003c\/td\u003e\u003c\/tr\u003e\u003ctr style=\"background:#F7F1E6\"\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD;width:32%;font-weight:600;color:#2B1E1A;vertical-align:top\"\u003eReferences\u003c\/td\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD\"\u003eEU (EudraLex, EMA) · PIC\/S · WHO · ICH · USA (21 CFR, FDA guidance) · United Kingdom (essential status) · USP–NF and Ph. Eur. (texts not reproduced) · ISO, EN and NSF\/ANSI standards · scientific literature\u003c\/td\u003e\u003c\/tr\u003e\u003ctr style=\"\"\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD;width:32%;font-weight:600;color:#2B1E1A;vertical-align:top\"\u003eSources and decisions\u003c\/td\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD\"\u003e99 sources in the Appendix B register · 91 decisions tracked in Appendix D\u003c\/td\u003e\u003c\/tr\u003e\u003ctr style=\"background:#F7F1E6\"\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD;width:32%;font-weight:600;color:#2B1E1A;vertical-align:top\"\u003eFree excerpt\u003c\/td\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD\"\u003e16 pages (ITA edition) · 16 pages (ENG edition)\u003c\/td\u003e\u003c\/tr\u003e\u003ctr style=\"\"\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD;width:32%;font-weight:600;color:#2B1E1A;vertical-align:top\"\u003eUpdates\u003c\/td\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD\"\u003eWhen the texts change, you receive the revised guide and toolkit at no extra cost.\u003c\/td\u003e\u003c\/tr\u003e\u003ctr style=\"background:#F7F1E6\"\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD;width:32%;font-weight:600;color:#2B1E1A;vertical-align:top\"\u003eDelivery\u003c\/td\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD\"\u003eDigital product: download of the ZIP file after payment. No shipping: the 3D image of the volume is a graphic rendering; there is no printed book.\u003c\/td\u003e\u003c\/tr\u003e\u003ctr style=\"\"\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD;width:32%;font-weight:600;color:#2B1E1A;vertical-align:top\"\u003eSoftware requirements\u003c\/td\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD\"\u003eA PDF reader; Microsoft Word; Excel 2016 or LibreOffice: the Excel workbooks were recalculated with LibreOffice in the Test Log runs. No macros, no external links; protected \"Ref_…\" reference sheets.\u003c\/td\u003e\u003c\/tr\u003e\u003ctr style=\"background:#F7F1E6\"\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD;width:32%;font-weight:600;color:#2B1E1A;vertical-align:top\"\u003eLicence\u003c\/td\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD\"\u003eIndividual use and internal use within the purchasing company: a personal, non-exclusive, non-transferable licence under the site's Legal Notice; printing for internal use only; sharing the files with third parties is prohibited.\u003c\/td\u003e\u003c\/tr\u003e\u003ctr style=\"\"\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD;width:32%;font-weight:600;color:#2B1E1A;vertical-align:top\"\u003ePrice\u003c\/td\u003e\u003ctd style=\"padding:10px 13px;border-bottom:1px solid #E6DCCD\"\u003e€179.00 per variant (guide + toolkit in the chosen language)\u003c\/td\u003e\u003c\/tr\u003e\u003c\/table\u003e\u003c\/div\u003e\u003cdiv style=\"background:#FFFFFF;border:1px solid #E6DCCD;border-left:4px solid #2B1E1A;border-radius:0 11px 11px 0;padding:18px 22px 6px 22px;margin-bottom:28px\"\u003e\u003cdiv style=\"font-weight:700;color:#2B1E1A;font-size:16px;margin-bottom:10px\"\u003eLimits of use\u003c\/div\u003e\u003cul style=\"margin:0 0 10px 0;padding-left:20px;font-size:15px;color:#33241F\"\u003e\u003cli style=\"margin:0 0 8px 0\"\u003eThe Excel workbooks are calculation templates with specification, tests and limits, \u003cstrong\u003enot validated software\u003c\/strong\u003e: before GMP use, the laboratory verifies them in its own quality system by repeating the relevant Test Log cases.\u003c\/li\u003e\u003cli style=\"margin:0 0 8px 0\"\u003eSimulated case: Torvenza Pharma S.p.A. is a fictitious company; its microbiology laboratory, batches and data are hypothetical. Every Torvenza value is a demonstration internal criterion, not a recommended value or an acceptance criterion.\u003c\/li\u003e\u003cli style=\"margin:0 0 8px 0\"\u003eNo sheet declares a method suitable or a result valid: the only outcomes are \"Comparison with the entered criteria\" or \"Assessment required\". The guide does not replace the assessment of the quality function and does not decide what happens to a batch.\u003c\/li\u003e\u003cli style=\"margin:0 0 8px 0\"\u003eThe guide does not replace the official texts cited and is not personalised legal, regulatory or quality advice. The species of the compendial strains are not reported: for strains, criteria and methods the current text prevails.\u003c\/li\u003e\u003cli style=\"margin:0 0 8px 0\"\u003eThe inspector questions are built for training and do not reproduce real findings; the fifteen FDA Warning Letters cited are verified, anonymised and each illustrates one topic. No guarantee of audit or inspection outcomes, which depend on context and application.\u003c\/li\u003e\u003cli style=\"margin:0 0 8px 0\"\u003eThe numerical examples were recalculated independently by the editorial team; the guide and the toolkit have not undergone independent third-party validation.\u003c\/li\u003e\u003c\/ul\u003e\u003c\/div\u003e\u003cdiv style=\"background:#F7F1E6;border:1px solid #E6DCCD;border-radius:11px;padding:18px 21px;margin-bottom:28px;font-size:14.5px;color:#33241F\"\u003e\u003cp style=\"margin:0 0 11px 0\"\u003e\u003cstrong style=\"color:#2B1E1A\"\u003eWho it is for.\u003c\/strong\u003e Heads and analysts of the QC microbiology laboratory, laboratory QA, sterility assurance, CQV, leads for sterility testing and isolators, endotoxins, media and strains, laboratory IT\/CSV, procurement and those who manage contract laboratories. It is written for those who \u003cstrong\u003eorganise, perform, verify or govern microbiological testing\u003c\/strong\u003e: sterility testing, bioburden and enumeration, endotoxins, rapid methods and identification, growth promotion, incubation, EM samples and laboratory equipment, and need to know which text every value comes from, with what force and in which jurisdiction.\u003c\/p\u003e\u003cp style=\"margin:0\"\u003e\u003cstrong style=\"color:#2B1E1A\"\u003eWho it is not for.\u003c\/strong\u003e It is not a guide to the environmental monitoring programme, to Annex 1 as a whole, to aseptic process simulation, to general instrument qualification or to data governance (the subjects of the sister guides linked on this page). Out of scope: validation of production sterilisation processes, containment levels and national biosafety legislation, mycoplasma and viral tests and cell-based preparations and tissues, container closure integrity testing and biological waste disposal; the microbiological assay of antibiotics and the antimicrobial effectiveness test are cited only as an interface.\u003c\/p\u003e\u003c\/div\u003e\u003cdiv\u003e\u003ch3 style=\"font-size:22px;margin:0 0 12px 0;color:#2B1E1A\"\u003eFrequently asked questions\u003c\/h3\u003e\u003cdiv style=\"margin-bottom:28px\"\u003e\u003cdiv style=\"border-bottom:1px solid #E6DCCD;padding:13px 0\"\u003e\u003cp style=\"margin:0 0 6px 0;font-weight:700;font-size:15px;color:#2B1E1A\"\u003eWhich language are the files in?\u003c\/p\u003e\u003cp style=\"margin:0;font-size:14.5px;color:#33241F\"\u003eThe language of the chosen variant: \u003cstrong\u003eITA - Italiano\u003c\/strong\u003e or \u003cstrong\u003eENG - English\u003c\/strong\u003e. Each purchase includes the guide and the toolkit in one language. There are no files in French, German or Spanish.\u003c\/p\u003e\u003c\/div\u003e\u003cdiv style=\"border-bottom:1px solid #E6DCCD;padding:13px 0\"\u003e\u003cp style=\"margin:0 0 6px 0;font-weight:700;font-size:15px;color:#2B1E1A\"\u003eIs it a printed book?\u003c\/p\u003e\u003cp style=\"margin:0;font-size:14.5px;color:#33241F\"\u003eNo. It is a digital product: after payment you download a ZIP file with the PDF and the tools. No shipping; the 3D image is only a rendering of the volume.\u003c\/p\u003e\u003c\/div\u003e\u003cdiv style=\"border-bottom:1px solid #E6DCCD;padding:13px 0\"\u003e\u003cp style=\"margin:0 0 6px 0;font-weight:700;font-size:15px;color:#2B1E1A\"\u003eDoes the guide give incubation times, recovery or GPT criteria that apply to everyone?\u003c\/p\u003e\u003cp style=\"margin:0;font-size:14.5px;color:#33241F\"\u003eNo, because no regulation sets them. It reports the values the sources state, with their nature (the 50–200% recovery in WHO TRS 961, Annex 2, is guidance for media only; the 30–35 °C and 20–25 °C in the 2004 FDA guidance for EM are indications; five passages from the collection culture are a convention), and the method for deciding the laboratory's own, each with its decision code (Chapters 10, 11 and 12).\u003c\/p\u003e\u003c\/div\u003e\u003cdiv style=\"border-bottom:1px solid #E6DCCD;padding:13px 0\"\u003e\u003cp style=\"margin:0 0 6px 0;font-weight:700;font-size:15px;color:#2B1E1A\"\u003eDo the tools say whether a method is suitable or a result is valid?\u003c\/p\u003e\u003cp style=\"margin:0;font-size:14.5px;color:#33241F\"\u003eNo. They return only \"Comparison with the entered criteria\" or \"Assessment required\"; missing data, exceedances or criteria not entered always lead to the latter, with the reason. The decision rests with the quality function.\u003c\/p\u003e\u003c\/div\u003e\u003cdiv style=\"border-bottom:1px solid #E6DCCD;padding:13px 0\"\u003e\u003cp style=\"margin:0 0 6px 0;font-weight:700;font-size:15px;color:#2B1E1A\"\u003eDoes it reproduce USP and Ph. Eur. criteria, tables and strains?\u003c\/p\u003e\u003cp style=\"margin:0;font-size:14.5px;color:#33241F\"\u003eNo. Compendial texts are sold by subscription: the guide reports their number, title, edition and status, describes the structure of the decision and does not give the species of the compendial strains. Ph. Eur. texts are reported from official EDQM sources, without direct consultation; for requirements, methods and criteria the current text prevails.\u003c\/p\u003e\u003c\/div\u003e\u003cdiv style=\"border-bottom:1px solid #E6DCCD;padding:13px 0\"\u003e\u003cp style=\"margin:0 0 6px 0;font-weight:700;font-size:15px;color:#2B1E1A\"\u003eHow does it handle rFC, method G and USP 〈86〉?\u003c\/p\u003e\u003cp style=\"margin:0;font-size:14.5px;color:#33241F\"\u003eWith the status of each text as of 04\/10\/2026: Ph. Eur. 2.6.32 current until 31\/12\/2026, method G of 2.6.14 from 01\/01\/2027 (published, not yet applicable), USP 〈86〉 official but not 'applicable', the March 2026 FDA Q\u0026amp;A Edition 2 current. Case C shows that the recombinant reagent alone does not solve masking (Chapter 8).\u003c\/p\u003e\u003c\/div\u003e\u003cdiv style=\"border-bottom:1px solid #E6DCCD;padding:13px 0\"\u003e\u003cp style=\"margin:0 0 6px 0;font-weight:700;font-size:15px;color:#2B1E1A\"\u003eDoes it cover the environmental monitoring programme?\u003c\/p\u003e\u003cp style=\"margin:0;font-size:14.5px;color:#33241F\"\u003eOnly as an interface. The guide covers the laboratory side: receipt, incubation, reading and counting of EM samples, air samplers and surface recovery. Sites, frequencies, limits and trends of the programme are in the Environmental Monitoring sister guide linked on this page.\u003c\/p\u003e\u003c\/div\u003e\u003cdiv style=\"border-bottom:1px solid #E6DCCD;padding:13px 0\"\u003e\u003cp style=\"margin:0 0 6px 0;font-weight:700;font-size:15px;color:#2B1E1A\"\u003eDoes it apply to the United States?\u003c\/p\u003e\u003cp style=\"margin:0;font-size:14.5px;color:#33241F\"\u003eThe main reference is the EU, with PIC\/S and WHO as guidance; for the United States the guide covers 21 CFR 211 and, for licensed biologics, 610 and 600.3, the FDA aseptic processing guidance (October 2004), the pyrogen and endotoxins Q\u0026amp;A Edition 2, the OOS guidance (May 2022, chemical scope) and the CGMP Q\u0026amp;As; the 1993 inspection guide and the FDA laboratory manuals are not guidance.\u003c\/p\u003e\u003c\/div\u003e\u003cdiv style=\"border-bottom:1px solid #E6DCCD;padding:13px 0\"\u003e\u003cp style=\"margin:0 0 6px 0;font-weight:700;font-size:15px;color:#2B1E1A\"\u003eAre the Excel workbooks validated?\u003c\/p\u003e\u003cp style=\"margin:0;font-size:14.5px;color:#33241F\"\u003eThey are not validated software. Each one has a Read_Me with the functional specification, readable formulas, error checks and a Test Log of the tests run: the laboratory verifies them in its own system before GMP use.\u003c\/p\u003e\u003c\/div\u003e\u003cdiv style=\"border-bottom:1px solid #E6DCCD;padding:13px 0\"\u003e\u003cp style=\"margin:0 0 6px 0;font-weight:700;font-size:15px;color:#2B1E1A\"\u003eWhat happens when the reference texts change?\u003c\/p\u003e\u003cp style=\"margin:0;font-size:14.5px;color:#33241F\"\u003eAppendix F lists the events that trigger re-verification of the guide: Ph. Eur. Issues 13.1, 13.2 and 13.3, new USP–NF Issues, Pharmacopeial Forum proposals, final texts of the EU drafts and the Annex 15 draft, standards in development. When the texts change, you receive the revised guide and toolkit at no extra cost. The revision on sale is shown on this page, with the regulatory verification date.\u003c\/p\u003e\u003c\/div\u003e\u003cdiv style=\"border-bottom:1px solid #E6DCCD;padding:13px 0\"\u003e\u003cp style=\"margin:0 0 6px 0;font-weight:700;font-size:15px;color:#2B1E1A\"\u003eCan I share the files with colleagues or a contract laboratory?\u003c\/p\u003e\u003cp style=\"margin:0;font-size:14.5px;color:#33241F\"\u003eThe licence is for individual use and internal use within the purchasing company, personal, non-exclusive and non-transferable: sharing the files with third parties, including contract laboratories, suppliers and external consultants, is prohibited. Printing is allowed for internal use only.\u003c\/p\u003e\u003c\/div\u003e\u003c\/div\u003e\u003c\/div\u003e\u003cdiv style=\"background:#F7F1E6;border:1px solid #E6DCCD;border-radius:12px;padding:20px 24px;margin-bottom:16px\"\u003e\u003cdiv style=\"font-size:17px;font-weight:700;color:#2B1E1A;margin-bottom:6px\"\u003eBefore you buy: the Microbiology Laboratory and Sterility Testing hub\u003c\/div\u003e\u003cp style=\"margin:0 0 12px 0;font-size:15px;color:#33241F\"\u003eThe 24 technical articles of the hub introduce the six themes of the guide, from the organisation of the microbiology laboratory to the qualification of a contract laboratory.\u003c\/p\u003e\u003ca href=\"https:\/\/www.guidegxp.com\/pages\/pharma-lab-microbiology-sterility\" style=\"color:#7A4A3A;font-weight:700;font-size:15px\"\u003eGo to the Microbiology Laboratory and Sterility Testing hub →\u003c\/a\u003e\u003c\/div\u003e\u003cdiv style=\"background:#2B1E1A;border-radius:12px;padding:24px 26px;color:#fff;margin-bottom:20px\"\u003e\u003cdiv style=\"font-size:18px;font-weight:700;margin-bottom:8px;color:#ffffff\"\u003eDo you have a positive sterility test, a microbiological OOS result or a method to make defensible?\u003c\/div\u003e\u003cdiv style=\"font-size:15px;color:#EFE6DA;margin-bottom:16px;max-width:660px\"\u003eDescribe the product or the test, the stage (method and suitability, routine, investigation or contract laboratory) and where you are stuck. GuideGxP will review the request and, where appropriate, may put you in touch with a specialist suited to your technical needs and your geographical area.\u003c\/div\u003e\u003ca href=\"https:\/\/www.guidegxp.com\/pages\/expert-support?area=lab-microbiology-sterility\u0026amp;source=product-gmp-microbiology-laboratory-sterility-testing-guide\u0026amp;cta=product-page\" style=\"display:inline-block;background:#EC6FA9;color:#2B1E1A;font-weight:700;font-size:15px;text-decoration:none;padding:11px 22px;border-radius:6px\"\u003eDescribe your situation →\u003c\/a\u003e\u003cdiv style=\"font-size:12.5px;color:#EFE6DA;margin-top:12px\"\u003eNo purchase obligation. The request is reviewed before any referral to a specialist.\u003c\/div\u003e\u003c\/div\u003e\u003cp style=\"font-size:12.5px;color:#5E4A40;margin:0\"\u003eGuideGxP guides do not replace official legislation or the guidance and standards cited (European Commission, EMA, PIC\/S, WHO, ICH, FDA, MHRA, EDQM, USP, ISO, CEN, NSF\/ANSI, PDA): they are operational support tools, do not constitute legal advice, and users remain responsible for the correct application of the rules in force in their own company context. Subscription texts are not reproduced. Numerical examples are for demonstration and are not acceptance criteria; the decision on the validity of a result and on what happens to a batch rests with the quality function. Regulatory status verified as of 04\/10\/2026. Torvenza Pharma S.p.A. is a fictitious company. Digital product: no physical shipping.\u003c\/p\u003e\u003c\/div\u003e","brand":"GuideGxP","offers":[{"title":"ITA - Italiano","offer_id":63804047851850,"sku":null,"price":179.0,"currency_code":"EUR","in_stock":true},{"title":"ENG - English","offer_id":63804047884618,"sku":null,"price":179.0,"currency_code":"EUR","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0955\/3320\/3786\/files\/GuideGxP_Microbiology_Lab_Cover_EN_v1.0_3D.png?v=1791442568","url":"https:\/\/www.guidegxp.com\/products\/gmp-microbiology-laboratory-sterility-testing-guide","provider":"GuideGxP","version":"1.0","type":"link"}